Als-Con-201 Exam Dumps - Salesforce Certified Agentforce Life Sciences Consultant

The correct answer is B because the requirement is about making a Samples option appear in the Life Sciences mobile app sidebar, not about adding a related list to a Salesforce desktop page. Salesforce Help for setting up the Life Sciences Cloud mobile app specifically includes tasks for configuring the Visit Engagement Page and the Sidebar Menu . Salesforce also states that mobile app configuration changes are handled through the Life Sciences Commercial app’s Admin Console and mobile configuration areas, with metadata cache used to sync configuration to the mobile device.

The Samples tab is part of the mobile visit engagement experience. Enabling the relevant Samples sidebar setting in Mobile App Settings makes the Samples entry available in the sidebar so reps can record sample disbursements during a visit. This is the correct configuration approach because it controls the mobile navigation and visit sidebar behavior.

Option A is incorrect because adding the Product Disbursements related list affects a record page layout, but it does not create the mobile sidebar tab required by the field sales team. Option C is also incorrect because simply placing a Lightning web component on the Visit Lightning record page does not necessarily add a Samples entry to the Life Sciences mobile sidebar menu. The consultant should enable the Samples sidebar setting in Mobile App Settings.

=========

The correct answer is A because Salesforce Life Sciences Territory Management batch jobs can be scheduled with an hourly frequency. Salesforce Help for running Territory Management jobs states that, from the Life Sciences Commercial Admin Console, the job can be scheduled hourly, every selected hours , by selecting the hour from the dropdown. This confirms that hourly scheduling is a supported automatic execution option for Territory Management batch jobs.

Territory Management batch jobs are important because Life Sciences territory configuration affects field execution, account alignment, provider access, and downstream engagement processes. Scheduling these jobs automatically helps ensure that territory-related processing runs on a predictable cadence without requiring administrators to manually start each batch job. When the question asks how often the jobs can be scheduled to execute automatically, the available option that matches Salesforce’s documented scheduling capability is Hourly .

Option B, Every 12 hours , may sound plausible because some enterprise batch processes use longer intervals, but it is not the best answer because Salesforce’s documented configuration describes hourly scheduling and selecting the hour interval. Option C, Monthly , is also incorrect because monthly execution would be too infrequent for many territory-management operational updates and is not the option reflected in the documented batch-job scheduling guidance. Therefore, the consultant should identify Hourly as the correct scheduling frequency.

The correct answer is C because the requirement is about sampling eligibility and validation behavior during visits. Salesforce Life Sciences sample management features support compliant handling and distribution of samples, and visit-related sample behavior is configured through visit settings and sample management setup. Salesforce Help describes sample management as enabling pharmaceutical companies to efficiently handle and distribute drug samples to providers, while the broader Customer Engagement setup includes Life Sciences mobile and visit configuration areas where these rules are applied.

The scenario includes two validation-style requirements. First, the consultant must specify which types of HCOs are eligible to receive samples. Second, the system must require users to enter a batch number for every sample drop. Both requirements are about enforcing rules during the sampling process, not about presenting product details or general sample item display.

Option A, Product Detailing Settings , is incorrect because product detailing is used to configure how products are discussed or presented during an engagement. It does not control HCO sample eligibility or mandatory batch entry. Option B, Samples and Items Settings , sounds related to sample availability, but the requirement is specifically about compliance validation. Option C, Sample and Validation Settings , is the correct subsection because it governs sample-related validation behavior, including eligibility and required information such as batch number entry. Therefore, the consultant should use Sample and Validation Settings .

=========

The correct answer is B because the requirement is persona-specific. Cumulus Pharma does not want the two additional custom objects to influence provider summaries for all users; the new insights and market intelligence must be used only when the provider summary is generated for the Key Account Manager profile. Salesforce Life Sciences Account Summarization is designed to generate contextual provider summaries from the latest changes, interactions, and insights related to a healthcare provider, and its configuration includes profile-specific setup so different personas can receive summaries grounded in the information relevant to their role.

Creating mapping records in the Provider Summary Profile Mappings tab associates the relevant summary data with the KAM profile. This is the most precise configuration because it controls which profile receives access to the additional summary context. Option A is not the best answer because creating a cross-object graph and assigning it directly to a profile is not the described administrative mechanism for persona-based provider summary control. Option C is also too broad: updating the Provider Summary Objects mapping may make the custom objects available to the summarization framework, but the key requirement is limiting usage to the new KAM persona. Profile mapping is what ensures the new objects are applied only for that persona’s provider summary generation.

=========

Option B is correct because the requirement is specifically to prevent visit creation when a Visit overlaps with a Time Off Territory record. Salesforce Life Sciences documentation references Time Off Territory overlapping rules as the standard mechanism that prevents creating visits during TOT events. Salesforce’s Winter ’26 Customer Engagement package patch notes also mention an issue where a visit could be created during a Time Off Territory event, bypassing the overlapping rule that should have prevented creation. That confirms TOT overlapping rules are the expected standard control for this scenario.

Because the business wants a hard stop, the overlapping rule behavior must be set to “Error.” This means the rep receives an error and cannot proceed with scheduling the visit while it conflicts with the TOT time block.

Option A is incorrect because a custom validation rule on Visit would duplicate a standard Life Sciences calendar/TOT capability and may not handle the full mobile scheduling experience correctly. Option C is also not the best answer because “Block Activity on Conflict” on the TOT record type is not the documented standard configuration in the Life Sciences Visit/Calendar settings. The correct standard configuration is to use TOT Overlapping Rules and set the overlap behavior to Error. This prevents scheduling visits during the rep’s logged time off.

=========

The correct answer is A because the subscription and channel must be connected before reps can capture consent for that channel. Salesforce’s Life Sciences Consent Management model includes Communication Subscription , Engagement Channel Type , and Communication Subscription Channel Type as standard entities for capturing and managing HCP consent and communication preferences. The Communication Subscription Channel Type object acts as the junction between a subscription topic, such as “Immunexis KOL Webinar Series,” and a channel, such as Email.

In the scenario, the subscription is visible, which confirms that the Communication Subscription record exists and is available in the mobile consent experience. However, Email is not selectable because the subscription has not been associated with the Email engagement channel. Creating the Communication Subscription Channel Type record resolves this gap by telling the system that this subscription can be consented to through the Email channel.

Option B is incorrect because Communication Subscription Consent records represent an individual HCP’s consent decision, such as opt-in or opt-out. They do not control whether a channel is available for a subscription. The channel must first be configured as valid for the subscription. After that, reps can capture the HCP’s opt-in preference during the visit. Therefore, the consultant should create the Communication Subscription Channel Type junction record.

=========

The correct answer is C because field sales reps only need to view and consume Tableau Next metrics in the Life Sciences mobile app. Salesforce Help for Tableau Next in Life Sciences Cloud explains that Tableau Next integrates with Life Sciences Cloud to provide actionable insights and enhanced visualizations. Salesforce’s Tableau Next permission guidance also identifies Tableau Next Consumer as the permission set used for viewing Tableau Next content and interacting with metrics, while creator-level access is intended for users who create and manage Tableau Next assets.

In this scenario, the technical setup has already been completed: the metrics exist, the Tableau View component has been placed on the Mobile Home Page Lightning record page, and the mobile metadata cache has been refreshed. The remaining issue is an insufficient-privileges error, which indicates that the user lacks the Tableau Next permissions required to load and consume the metric. Assigning Tableau Next Consumer grants the field rep the appropriate access level without giving unnecessary authoring privileges.

Option A, Tableau Next Creator , is incorrect because field sales reps are not creating or administering metrics; they only need to consume them. Option B, CRM Analytics Plus User , is also incorrect because the requirement is specifically for Tableau Next metrics, not legacy CRM Analytics access. Therefore, the consultant should assign the Tableau Next Consumer permission set.

=========

Option B is correct because the two requirements depend on two different territory-related maintenance jobs, and the territory information should be refreshed before historical visit sharing is recalculated. Salesforce’s Life Sciences Cloud documentation describes Provider Account Territory Information as engagement data between an account and a user within an assigned territory, including visit-related information such as next provider visit date and preferred address. After a major territory realignment, this data must be updated first so that territory-based account and visit metrics reflect the new alignments.

After that, the Visit Share Management job should be run. Salesforce Help states that, to share historical account visit records after territory realignments, admins run the Visit Share Management job so field users continue to have access to relevant historical visit data. That exactly matches the second requirement in the question: newly assigned reps must gain access to historical visit data for accounts that now belong to their territories.

Option A is incorrect because the question asks for the correct sequence, and Salesforce documentation does not indicate that Visit Share Management should be relied on to automatically execute the territory information update job. Option C is incorrect because running visit sharing before updating provider-account-territory information can share records based on stale territory data. Therefore, the correct operational sequence is: update Provider Account Territory Information first, then run Visit Share Management.

=========